| SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls N Le Bert, AT Tan, K Kunasegaran, CYL Tham, M Hafezi, A Chia, ... Nature 584 (7821), 457-462, 2020 | 2065 | 2020 |
| Different pattern of pre-existing SARS-COV-2 specific T cell immunity in SARS-recovered and uninfected individuals NL Bert, AT Tan, K Kunasegaran, CYL Tham, M Hafezi, A Chia, M Chng, ... BioRxiv, 2020.05. 26.115832, 2020 | 40 | 2020 |
| Immunosuppressive drug‐resistant armored T‐cell receptor T cells for immune therapy of HCC in liver transplant patients M Hafezi, M Lin, A Chia, A Chua, ZZ Ho, R Fam, D Tan, J Aw, A Pavesi, ... Hepatology 74 (1), 200-213, 2021 | 38 | 2021 |
| Dysregulated expression of Tim-3 and NKp30 receptors on NK cells of patients with chronic lymphocytic leukemia L Hadadi, M Hafezi, AA Amirzargar, RA Sharifian, S Abediankenari, ... Oncology research and treatment 42 (4), 197-203, 2019 | 37 | 2019 |
| Myeloid-derived suppressor cells elimination by 5-fluorouracil increased dendritic cell-based vaccine function and improved immunity in tumor mice J Hadjati, A Namdar, R Boghozian, M Hafezi, M Ashourpour, ... Iranian Journal of Allergy, Asthma and Immunology, 47-55, 2018 | 19 | 2018 |
| Personalized armored TCR-redirected T cell therapy for liver/organ transplant with recurrent cancer M Hafezi, A Tan, A Bertoletti Cells 10 (8), 1861, 2021 | 4 | 2021 |
| Low noncytotoxic concentrations of 5-fluorouracil have no adverse effects on maturation and function of bone marrow-derived dendritic cells in vitro: a potentially safe … A Namdar, HR Mirzaei, M Hafezi, N Khosravianfar, N Kheshtchin, ... International Archives of Allergy and Immunology 168 (2), 122-130, 2016 | 4 | 2016 |
| Personalized T-cell therapy in liver transplanted patients with hepatitis B virus related hepatocellular carcinoma M Hafezi, A Bertoletti, A Tan Hepatoma Res 2020, 23, 2020 | 3 | 2020 |
| Olive leaf extract reduces myeloid-derived suppressor cells, and modulates the function of residual cells in experimental model of melanoma M Ashourpour, A Namdar, N Kheshtchin, M Hafezi, N Khosravianfar J Clin Exp Oncol 5 3, 2, 2016 | 3 | 2016 |
| T cell immunotherapy in hepatitis B virus related hepatocellular carcinoma M Hafezi, A Bertoletti, AT Tan Hepatoma Res 4, 16, 2018 | 2 | 2018 |
| Immunosuppressant drug resistant armored tcr t cells for immune-therapy of organ transplant patients A Bertoletti, AT Tan, M Hafezi US Patent App. 18/044,429, 2023 | | 2023 |
| Different pattern of pre-existing SARS-COV-2 specific T cell immunity in SARS-recovered and uninfected individuals (preprint) N Le Bert, AT Tan, K Kunasegaran, CYL Tham, M Hafezi, A Chia, M Chng, ... | | 2020 |
| DIFFERENTIAL EFFECTS OF IMMUNOSUPPRESSANTS ON THE FUNCTION OF ENGINEERED TCR-T CELLS M HAFEZI | | 2019 |
| Ikk2 regulates tissue integrity and innate immunity in zebrafish at the level of cytokinesis H Shen, M Hafezi, V Tergaonkar, V Korzh Mechanisms of Development, S62, 2017 | | 2017 |
Antonio BertolettiDuke-Nus Medical SchoolVerified email at duke-nus.edu.sg
